P. Leren

发表

The Oslo Study: diet and antismoking advice. Additional results from a 5-year primary preventive trial in middle-aged men.

I. Holme, I. Hjermann, A. Helgeland, 1985, Preventive medicine.

Risk Factors of Stroke Incidence and Mortality: A 12‐Year Follow‐up of the Oslo Study

I. Holme, I. Hjermann, L. Håheim, 1993, Stroke.

Serum triglycerides as an independent risk factor for death from coronary heart disease in middle-aged Norwegian men.

I. Holme, A. Tverdal, P. Leren, 1989, American journal of epidemiology.

Smoking habits and risk of fatal stroke: 18 years follow up of the Oslo Study.

I. Holme, I. Hjermann, L. Håheim, 1996, Journal of epidemiology and community health.

The predictability of risk factors with respect to incidence and mortality of myocardial infarction and total mortality. A 12‐year follow‐up of the Oslo Study, Norway

I. Holme, I. Hjermann, L. Håheim, 1993, Journal of internal medicine.

The effect on HDL cholesterol of oxprenolol and atenolol.

I. Holme, S. Kjeldsen, P. Leren, 1982, Scandinavian journal of clinical and laboratory investigation.

HDL-cholesterol in antihypertensive treatment. The Oslo Study.

I. Holme, I. Hjermann, S. Enger, 2009, Acta medica Scandinavica. Supplementum.

The effect of dietary changes on high density lipoprotein cholesterol. The Oslo Study.

I. Holme, I. Hjermann, S. Enger, 1979, The American journal of medicine.

The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial.

P. Leren, 1966, Acta medica Scandinavica. Supplementum.

EFFECT OF PROPRANOLOL AND PRAZOSIN ON BLOOD LIPIDS The Oslo Study

I. Holme, I. Hjermann, A. Helgeland, 1980, The Lancet.

Risk Factors for Coronary and Cerebral Atherosclerosis in the Oslo Study

L. Solberg, J. Strong, I. Holme, 1980 .

Maximal low density lipoprotein receptor activity and the effect of lipid lowering diet on total serum cholesterol

I. Hjermann, A. Børresen, K. Berg, 1985, Clinical genetics.

Serum glucose levels during long-term observation of treated and untreated men with mild hypertension. The Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 1984, The American journal of medicine.

Quality-adjusted meta-analysis of the hypertension/coronary dilemma.

I. Holme, I. Hjermann, L. Ekelund, 1994, American journal of hypertension.

years follow up of the Oslo Study . Smoking habits and risk of fatal stroke : 18

I. Holme, I. Hjermann, L. Håheim, 2022 .

MRFIT and the Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 1983, Journal of the American Medical Association (JAMA).

Physical activity at work and at leisure in relation to coronary risk factors and social class. A 4-year mortality follow-up. The Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 2009, Acta medica Scandinavica.

Socio-economic status as a coronary risk factor: the Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 2009, Acta medica Scandinavica. Supplementum.

CORONARY RISK FACTORS AND SOCIOECONOMIC STATUS The Oslo Study

I. Holme, I. Hjermann, A. Helgeland, 1976, The Lancet.

Risk Factors and Raised Atherosclerotic Lesions in Coronary and Cerebral Arteries

L. Solberg, J. Strong, I. Holme, 1981, Arteriosclerosis.

Lipid effects of antihypertensive drugs.

P. Leren, 1990, Clinical and experimental hypertension. Part A, Theory and practice.

Smoking and Atherosclerotic Disease. The Oslo Study

L. Solberg, I. Holme, I. Hjermann, 1983 .

High density lipoprotein cholesterol and myocardial infarction or sudden coronary death: a prospective case-control study in middle-aged men of the Oslo study.

I. Holme, I. Hjermann, S. Enger, 1979, Artery.

Increased plasma vasopressin in low renin essential hypertension.

I. Hjermann, S. Kjeldsen, K. Lande, 1986, Hypertension.

Effect of alpha- and beta-blocker therapy on blood lipids: European experience.

P. Leren, 1984, The American journal of medicine.

Decreased peripheral dopaminergic activity in essential hypertension?

S. Kjeldsen, A. Helgeland, P. Leren, 1983, Scandinavian journal of clinical and laboratory investigation.

Aging and urinary vasopressin excretion in healthy men.

I. Hjermann, S. Kjeldsen, I. Os, 1987, Scandinavian journal of urology and nephrology.

Evidence of age-related variation in plasma vasopressin of normotensive men.

I. Hjermann, S. Kjeldsen, I. Os, 1985, Scandinavian journal of clinical and laboratory investigation.

High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study.

I. Holme, I. Hjermann, S. Enger, 1978, British medical journal.

Antihypertensive drugs and blood lipids: the Oslo study.

I. Holme, I. Hjermann, S. Kjeldsen, 1982, British journal of clinical pharmacology.

Possible metabolic side effects of beta-adrenergic blocking drugs.

I. Holme, I. Hjermann, A. Helgeland, 1978, British medical journal.

Antihypertensive Drugs and Blood Lipids: The Oslo Study

I. Holme, I. Hjermann, S. Kjeldsen, 1982, Journal of cardiovascular pharmacology.

Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. The Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 1978, The American journal of medicine.

Arterial plasma norepinephrine correlates to blood pressure in middle-aged men with sustained essential hypertension.

N. Schork, S. Kjeldsen, P. Leren, 1989, American heart journal.

Plasma adrenaline: relations to blood pressure, blood platelet function and blood lipids in essential hypertension.

S. Kjeldsen, K. Gjesdal, K. Lande, 1988, Pharmacology & toxicology.

Increased plasma vasopressin and serum uric acid in the low renin type of essential hypertension.

S. Kjeldsen, I. Os, P. Leren, 2009, Acta medica Scandinavica.

Influence of body weight on plasma catecholamine patterns in middle-aged, normotensive men.

S. Kjeldsen, P. Leren, I. Aakesson, 1983, Scandinavian journal of clinical and laboratory investigation.

Further evidence for an association between the Xbal polymorphism at the apolipoprotein B locus and lipoprotein level

I. Hjermann, K. Berg, P. Leren, 1988, Clinical genetics.

Treatment of Borderline and Mild Hypertension: The Oslo Study

I. Holme, I. Hjermann, A. Helgeland, 1981 .

The lipid pattern in normals and atherosclerotics.

P. Leren, O. Haabrekke, 2009, Acta medica Scandinavica.

Long-term effect of lovastatin alone and in combination with cholestyramine on lipoprotein (a) level in familial hypercholesterolemic subjects

I. Hjermann, K. Berg, P. Leren, 1992, The clinical investigator.

Risk of fatal stroke according to blood pressure level: an 18-year follow-up of the Oslo Study

I. Holme, I. Hjermann, L. Håheim, 1995, Journal of hypertension.

Increased peripheral release of noradrenaline and uptake of adrenaline in essential hypertension?

S. Kjeldsen, A. Helgeland, P. Leren, 1981, Clinical science.

The effect of enalapril and timolol on blood lipids. A randomized multicenter hypertension study in general practice in Norway.

P. Leren, P. O. Foss, B. Nordvik, 2009, Acta medica Scandinavica.

The effect of sodium depletion and potassium supplementation on vasopressin, renin and catecholamines in hypertensive men.

S. Kjeldsen, I. Os, P. Leren, 2009, Acta medica Scandinavica.

Arteriovenous difference of plasma vasopressin in normal man and effect of posture.

S. Kjeldsen, I. Os, P. Leren, 1984, Acta physiologica Scandinavica.

Evidence of increased peripheral catecholamine release in patients with long-standing, untreated essential hypertension.

S. Kjeldsen, A. Helgeland, P. Leren, 1982, Scandinavian journal of clinical and laboratory investigation.

Increased platelet release reaction in 50-year-old men with essential hypertension: correlation with atherogenic cholesterol fractions.

S. Kjeldsen, K. Gjesdal, K. Lande, 1987, American heart journal.

Effects of posture on serum cholesterol fractions, cholesterol ratio and triglycerides.

S. Kjeldsen, P. Leren, I. Eide, 1983, Scandinavian journal of clinical and laboratory investigation.

Oslo Study Diet and Antismoking Trial. Results after 102 months.

I. Holme, I. Hjermann, P. Leren, 1986, The American journal of medicine.

Selection of initial antihypertensive therapy: new perspectives on coronary heart disease. Risk factors provide new insights. Introduction.

P. Leren, R. Levey, 1986, The American journal of medicine.

The intercorrelation of serum cholesterol, cigarette smoking and body weight. The Oslo Study.

I. Holme, I. Hjermann, A. Helgeland, 2009, Acta medica Scandinavica.

Sixteen years of plasma exchange in a homozygote for familial hypercholesterolaemia

P. Leren, M. Fagerhol, T. Leren, 1993, Journal of internal medicine.

Plasma adrenaline and noradrenaline during orthostasis in man: the importance of arterial sampling.

S. Kjeldsen, P. Leren, A. Westheim, 1986, Scandinavian journal of clinical and laboratory investigation.

Increased arterial catecholamine concentrations in 50-year-old men with essential hypertension.

S. Kjeldsen, P. Leren, I. Aakesson, 1983, Scandinavian journal of clinical and laboratory investigation.

Mild hypertension--early drug treatment or follow-up only? The Oslo study.

A. Helgeland, P. Leren, I. B. Aasen, 2009, Acta medica Scandinavica. Supplementum.

[The Oslo study. 4-year mortality, coronary risk factors and socioeonomic indicators].

I. Holme, I. Hjermann, A. Helgeland, 1980, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

Severe sodium restriction alone and with potassium supplementation does not alter blood lipoproteins in essential hypertension

S. Kjeldsen, P. Leren, A. Westheim, 1987, European journal of clinical investigation.

Comparison of effects on lipid metabolism of antihypertensive drugs with alpha- and beta-adrenergic antagonist properties.

P. Leren, 1987, The American journal of medicine.

Decreased Platelet-Free Dopamine and Unchanged Noradrenaline and Adrenaline in Essential Hypertension

S. Kjeldsen, K. Gjesdal, P. Leren, 1988, Thrombosis and Haemostasis.

The Oslo Diet‐Heart Study: Eleven‐Year Report

P. Leren, 1970, Circulation.

Increased beta-thromboglobulin in essential hypertension: interactions between arterial plasma adrenaline, platelet function and blood lipids.

S. Kjeldsen, K. Gjesdal, P. Leren, 1983, Acta medica Scandinavica.

Increased plasma free dopamine after treatment with atenolol and oxprenolol in essential hypertension.

S. Kjeldsen, P. Leren, I. Aakesson, 2009, Acta medica Scandinavica.

Increased peripheral catecholamine release in patients with long-standing, untreated essential hypertension.

S. Kjeldsen, A. Helgeland, P. Leren, 2009, Acta medica Scandinavica. Supplementum.

Treatment of mild hypertension with diuretics. The importance of ECG abnormalities in the Oslo Study and in MRFIT.

I. Holme, I. Hjermann, A. Helgeland, 1984, JAMA.

Changes in the lipoprotein profile during antihypertensive therapy.

S. Kjeldsen, A. Helgeland, P. Leren, 2009, Acta pharmacologica et toxicologica.

Blood lipids in patients with atherosclerosis obliterans of the lower limbs.

P. Leren, O. Haabrekke, 2009, Acta medica Scandinavica.

Ischaemic heart disease: how well are the risk profiles modulated by current beta blockers?

P. Leren, 1993, Cardiology.

[SYNCHRONIZED DIRECT CURRENT SHOCK IN CARDIAC ARRHYTHMIAS].

E. Sivertssen, P. Leren, 1965, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

Urban air pollution and mortality in a cohort of Norwegian men.

B. Oftedal, P. Nafstad, I. Holme, 2004, Environmental health perspectives.

Sodium depletion increases platelet and plasma catecholamines in hypertensive men.

S. Kjeldsen, K. Gjesdal, E. Enger, 1988, Hypertension.

Oslo Hypertension Study

A. Helgeland, P. Leren, 2012, Drugs.

Correlates of blood pressure change in middle-aged male mild hypertensives: results from the untreated control group in the Oslo hypertension trial. The Oslo Study.

I. Holme, I. Hjermann, A. Helgeland, 1988, American journal of epidemiology.

Oslo Study: Treatment of Mild Hypertension

A. Helgeland, P. Leren, 1987 .

Coronary heart disease and treatment of hypertension. Some Oslo Study data.

A. Helgeland, P. Leren, 1986, The American journal of medicine.

Increased β‐Thromboglobulin in Essential Hypertension: Interactions between Arterial Plasma Adrenaline, Platelet Function and Blood Lipids

S. Kjeldsen, K. Gjesdal, P. Leren, 2009 .

The Hypertension‐CHD Dilemma

P. Leren, 2009 .

Blood platelet release correlates with serum lipids in 50 year old men with essential hypertension.

S. Kjeldsen, K. Gjesdal, K. Lande, 2009, Acta medica Scandinavica. Supplementum.

EFFECT OF DIET AND SMOKING INTERVENTION ON THE INCIDENCE OF CORONARY HEART DISEASE Report from the Oslo Study Group of a Randomised Trial in Healthy Men

I. Holme, I. Hjermann, P. Leren, 1981, The Lancet.

Increased erythrocyte magnesium content in essential hypertension.

S. Kjeldsen, O. Sejersted, P. Leren, 1990, Scandinavian journal of clinical and laboratory investigation.

Mortality in relation to smoking history: 13 years' follow-up of 68,000 Norwegian men and women 35-49 years.

D. Thelle, A. Tverdal, P. Leren, 1993, Journal of clinical epidemiology.

Binding of quinidine in sera with different levels of triglycerides, cholesterol, and orosomucoid protein.

P. Leren, O. G. Nilsen, S. Jacobsen, 1978, Biochemical pharmacology.

Myxoma of the heart; polypoid tumor of the left atrium diagnosed ante mortem.

P. Leren, K. Kirkeby, 2009, Acta medica Scandinavica.

Blood lipids in patients with coronary heart disease.

P. Leren, O. Haabrekke, 2009, Acta medica Scandinavica.

Lung cancer and air pollution: a 27 year follow up of 16 209 Norwegian men

B. Oftedal, P. Nafstad, I. Holme, 2003, Thorax.

The Oslo study. Cardiovascular disease in middle-aged and young Oslo men.

I. Holme, I. Hjermann, A. Helgeland, 1975, Acta medica Scandinavica. Supplementum.

Prognostic significance of ECG-changes in survivors of myocardial infarction. Five-year follow-up study.

I. Hjermann, P. Leren, J. Björnson, 2009, Acta medica Scandinavica.

Four and two-thirds years incidence of coronary heart disease in middle-aged men: the Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 1980, American journal of epidemiology.

Coronary risk factors and their pathway of action through coronary raised lesions, coronary stenoses and coronary death. Multivariate statistical analysis of an autopsy series: the Oslo Study.

L. Weissfeld, O. Williams, L. Solberg, 1985, The American journal of cardiology.

Sex-specific relevance of diabetes to occlusive vascular and other mortality : a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies

R. Collins, D. Levy, E. Rimm, 2019 .

The electrocardiographic pattern and mortality risk in post-myocardial infarction patients. An 11-year follow-up study.

I. Hjermann, P. Leren, J. Björnson, 2009, Acta medica Scandinavica.

The effect of plasma-cholesterol-lowering diet in male survivors of myocardial infarction. A controlled clinical trial.

P. Leren, 1968, Bulletin of the New York Academy of Medicine.

Diet-heart era: premature obituary?

K. Kohn, N. Stone, W. J. Walker, 1978, The New England journal of medicine.

Cancer among men on cholesterol-lowering diets: Experience from five clinical trials.

F. Ederer, P. Leren, I. Frantz, 1971, Lancet.

Serum insulin response to oral glucose load during a dietary intervention trial in healthy coronary high risk men: the Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 1980, Scandinavian journal of clinical and laboratory investigation.

Four-year mortality by some socioeconomic indicators: the Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 1980, Journal of epidemiology and community health.

Coronary risk factors in various occupational groups: the Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 1977, British journal of preventive & social medicine.

Prevention of coronary heart disease: some results from the Oslo secondary and primary intervention studies.

P. Leren, 1989, Journal of the American College of Nutrition.

Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia.

I. Hjermann, K. Berg, P. Leren, 1988, Atherosclerosis.

Blood lipids in normals.

P. Leren, O. Haabrekke, 2009, Acta medica Scandinavica.

Childhood traumas and psychosocial characteristics of 50-year-old men with essential hypertension.

S. Kjeldsen, O. Ekeberg, P. Leren, 1990, Journal of psychosomatic research.

Trends in the incidence of acute myocardial infarction and stroke: a 21‐year follow‐up of the Oslo study

S. Tonstad, I. Holme, I. Hjermann, 2004, Scandinavian cardiovascular journal : SCJ.

[Coronary risk factors and socioeconomic status. The Oslo study].

I. Holme, I. Hjermann, A. Helgeland, 1977, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

The association between blood pressure and serum cholesterol in healthy men: the Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 1978, Journal of epidemiology and community health.

Increased Plasma Noradrenaline During Severe Sodium Restriction Does Not Stimulate Platelet Release in Essential Hypertension

S. Kjeldsen, K. Gjesdal, K. Lande, 1986, Thrombosis and Haemostasis.

Effect of lipid lowering diet on low density lipoprotein receptor activity in freshly isolated peripheral blood mononuclear cells.

I. Hjermann, K. Berg, P. Leren, 2009, Acta Medica Scandinavica.

Stenoses in the coronary arteries. Relation to atherosclerotic lesions, coronary heart disease, and risk factors. The Oslo Study.

L. Solberg, J. Strong, I. Holme, 1985, Laboratory investigation; a journal of technical methods and pathology.

Predictiveness of body mass index for fatal coronary heart disease in men according to length of follow-up: A 21-year prospective cohort study

S. Tonstad, I. Holme, I. Hjermann, 2007, Scandinavian journal of public health.

Does Increased Platelet Release Normalize During Anti-Hypertensive Treatment?

S. Kjeldsen, K. Gjesdal, K. Lande, 1987, Thrombosis and Haemostasis.

[The effect of a cholesterol lowering diet in male survivors of myocardial infarction. (A controlled clinical trial)].

P. Leren, 1967, Nordisk medicin.

Nonfasting serum glucose and the risk of fatal stroke in diabetic and nondiabetic subjects. 18-year follow-up of the Oslo Study.

I. Holme, I. Hjermann, L. Håheim, 1995, Stroke.

Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies

R. Collins, R. Kronmal, E. Vartiainen, 2018, The lancet. Diabetes & endocrinology.

Association between Risk Factors and Atherosclerotic Lesions Based on Autopsy Findings in the Oslo Study: A Preliminary Report

L. Solberg, J. Strong, I. Holme, 1977 .

The prognostic value of arrhythmias at rest and in connection with an exercise stress test in the late hospital phase of acute myocardial infarction.

E. Sivertssen, P. Leren, O. Skjaeggestad, 1978, Journal of the Oslo city hospitals.

The Oslo study: CHD risk factors, socioeconomic influences, and intervention.

I. Holme, I. Hjermann, A. Helgeland, 1983, American heart journal.